listen and subscribe
Choose your preferred player:
Please enable JavaScript to get the Slate Plus feed.
Get the Slate Plus Podcast
If you can’t access your feed, contact customer support.
Listen on your computer:
Apple Podcasts only works on MacOS operating systems. catalina. Android apps on desktop are not supported at this time.
Listen on your device:Recommended
These links only work if you’re using a device that listens to podcasts. Stitchers are not supported at this time.
episode notes
Semaglutide, also known as Ozempic, has been making headlines as a weight-loss drug, even though it is only FDA-approved for diabetes. Some people now say it helps calm cravings for food as well as cravings for alcohol, drugs, and other compulsive behaviors. Researchers have long studied the efficacy of Ozempic as an addiction treatment in animals. what did they find? And will it actually work?
The guests: Sarah Chan The Atlantic health and medical coverage
If you like this show, please consider subscribing to Slate Plus. Slate Plus members get benefits like zero ads on the Slate podcast, bonus episodes of him on shows like Slow Burn and his Amicus. You will also support the work we are doing on What Next TBD. Sign up today at slate.com/whatnextplus to support our efforts.
The podcast is produced by Evan Campbell.
